Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  CYANOTECH CORP    CYAN

CYANOTECH CORP (CYAN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsCompany 
News SummaryMost relevantAll newsSector newsTweets

CYANOTECH : Michael A. Davis Named Chairman of the Board of Directors of Cyanotech

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/21/2011 | 02:10pm CET

Michael A. Davis has been elected as Chairman of the Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN). He replaces Gregg Robertson, who resigned in late 2010.

Mr. Davis was Vice-Chairman of the Board and has been a Director of Cyanotech since March 2003.

"Michael has been a key influence in helping Cyanotech sharpen its business model and market focus in recent years," said Brent Bailey, President and CEO. "We look forward to his continuing support and leadership as Chairman of the Board."

Mr. Davis, a private Investor and major shareholder of Cyanotech since 1994, is also President of Skywords Family Foundation and a Director of Canobie Films, Inc.

About Cyanotech -- Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®--all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's Spirulina products offer complete nutrition, and augment energy and immune response. They are FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use in food products. BioAstin's superior antioxidant activity and ability to support and maintain a natural anti-inflammatory response enhance skin, muscle and joint health. All Cyanotech products are produced from microalgae grown at its 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers in more than 54 countries worldwide. Cyanotech was the first microalgae company in the world to obtain quality management standards ISO 9001:2000 certification and is GMP-certified by the Natural Products AssociationTM. Visit www.cyanotech.com for more information.

Cyanotech Corporation
Bruce Russell, 310-559-4955 x101


© Business Wire 2011
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CYANOTECH CORP
02/06CYANOTECH : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
02/06CYANOTECH : Reports Financial Results for the Third Quarter of Fiscal Year 2018
BU
01/30CYANOTECH : names new CEO
AQ
01/25CYANOTECH CORP : Change in Directors or Principal Officers, Other Events, Financ..
AQ
01/24CYANOTECH : Names Mawae Morton as Chief Executive Officer and a Member of the Bo..
BU
2017CYANOTECH : earns $475K in second quarter
AQ
2017CYANOTECH : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
2017CYANOTECH : Reports Financial Results for the Second Quarter of Fiscal Year 2018
BU
2017CYANOTECH CORPORATION (NASDAQ : CYAN) Files An 8-K Submission of Matters to a Vo..
AQ
2017CYANOTECH CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
More news
News from SeekingAlpha
02/06Midday Gainers / Losers (2/6/2018) 
02/06HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (2/6/2018) 
02/06Cyanotech FQ3 sales up 20%; earnings up 417%; shares up 28% 
02/06Cyanotech reports Q3 results 
2017Cyanotech Corporation's (CYAN) CEO Gerry Cysewski on Q3 2017 Results - Earnin.. 
Chart CYANOTECH CORP
Duration : Period :
CYANOTECH CORP Technical Analysis Chart | CYAN | US2324373016 | 4-Traders
Managers
NameTitle
Mawae Morton Chief Executive Officer & Director
Michael A. Davis Chairman
Gerard J. Watts Chief Operating Officer
Jolé Eileen Deal CFO, Secretary, Treasurer & VP-Administration
Gerald R. Cysewski Vice Chairman & Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
CYANOTECH CORP21.64%0
BIOGEN-7.06%63 312
CSL LIMITED7.22%54 288
ALEXION PHARMACEUTICALS3.02%27 311
GRIFOLS SA-4.40%18 471
BIOMARIN PHARMACEUTICAL-5.19%14 847